"Mit dem geriatrischen Schwerpunkt sind wir auf die Diagnostik und Therapie von akuten und chronischen Erkrankungen des Alters spezialisiert. Wir bieten alten und sehr alten Patienten eine zuverlässige Anlaufstelle in Bielefeld. In der geriatrischen Behandlung haben wir das Ziel, die Lebensqualität unserer Patienten zu verbessern und ihre Unabhängigkeit so lange wie möglich zu erhalten. Dafür bietet unsere Klinik neben einem stationären Aufenthalt auch die teilstationäre Behandlung in unserer Tagesklinik an. Durch die Einbindung in das EvKB, die v. Bodelschwinghschen Stiftungen Bethel wie auch das Ev. Johanneswerk sind wir in der Lage verschiedenste Hilfs- und Pflegeangebote für ältere und pflegebedürftige Menschen zu vermitteln."

During the past decade, Ev.Krankenhaus Bielefeld gGmbH; Klinik für Innere Medizin und Geriatrie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ev.Krankenhaus Bielefeld gGmbH; Klinik für Innere Medizin und Geriatrie" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Ev.Krankenhaus Bielefeld gGmbH; Klinik für Innere Medizin und Geriatrie" in a lesser frequency.

Most popular intervention types in "Ev.Krankenhaus Bielefeld gGmbH; Klinik für Innere Medizin und Geriatrie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ev.Krankenhaus Bielefeld gGmbH; Klinik für Innere Medizin und Geriatrie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ev.Krankenhaus Bielefeld gGmbH; Klinik für Innere Medizin und Geriatrie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ev.Krankenhaus Bielefeld gGmbH; Klinik für Innere Medizin und Geriatrie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ev.Krankenhaus Bielefeld gGmbH; Klinik für Innere Medizin und Geriatrie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".